BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38685144)

  • 1. Stakeholders' perspectives and experiences of the pharmacist's role in deprescribing in ambulatory care: A qualitative meta-synthesis.
    Kassis A; Moles R; Carter S
    Res Social Adm Pharm; 2024 Aug; 20(8):697-712. PubMed ID: 38685144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Professional roles of general practitioners, community pharmacists and specialist providers in collaborative medication deprescribing - a qualitative study.
    Gerlach N; Michiels-Corsten M; Viniol A; Schleef T; Junius-Walker U; Krause O; Donner-Banzhoff N
    BMC Fam Pract; 2020 Sep; 21(1):183. PubMed ID: 32887551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stakeholder perspectives on pharmacist involvement in a memory clinic to review patients' medication management and assist with deprescribing.
    Cross AJ; Le VJ; George J; Woodward MC; Elliott RA
    Res Social Adm Pharm; 2020 May; 16(5):681-688. PubMed ID: 31405811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knowledge and willingness of physicians about deprescribing among older patients: a qualitative study.
    AlRasheed MM; Alhawassi TM; Alanazi A; Aloudah N; Khurshid F; Alsultan M
    Clin Interv Aging; 2018; 13():1401-1408. PubMed ID: 30122912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structured medication reviews in Parkinson's disease: pharmacists' views, experiences and needs - a qualitative study.
    Oonk NGM; Dorresteijn LDA; Te Braake E; Movig KLL; van der Palen J; Nijmeijer HW; van Kesteren ME; Bode C
    Ther Adv Drug Saf; 2024; 15():20420986241237071. PubMed ID: 38694547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing deprescribing: A qualitative understanding of the complexities of pharmacist-led deprescribing in care homes.
    Birt L; Wright DJ; Blacklock J; Bond CM; Hughes CM; Alldred DP; Holland R; Scott S
    Health Soc Care Community; 2022 Nov; 30(6):e6521-e6531. PubMed ID: 36336895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perceptions of pharmacists' roles in the era of expanding scopes of practice.
    Schindel TJ; Yuksel N; Breault R; Daniels J; Varnhagen S; Hughes CA
    Res Social Adm Pharm; 2017; 13(1):148-161. PubMed ID: 27061142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deprescribing in a multimorbid older adult: A case vignette study among community pharmacists and primary care physicians.
    Bužančić I; Ortner Hadžiabdić M
    Basic Clin Pharmacol Toxicol; 2023 Dec; 133(6):729-740. PubMed ID: 37177977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qualitative meta-synthesis of barriers and facilitators that influence the implementation of community pharmacy services: perspectives of patients, nurses and general medical practitioners.
    Hossain LN; Fernandez-Llimos F; Luckett T; Moullin JC; Durks D; Franco-Trigo L; Benrimoj SI; Sabater-Hernández D
    BMJ Open; 2017 Sep; 7(9):e015471. PubMed ID: 28877940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to Deprescribe Potentially Inappropriate Medications During the Hospital-to-Home Transition: Stakeholder Perspectives on Essential Tasks.
    Wang J; Shen JY; Yu F; Nathan K; Caprio TV; Conwell Y; Moskow MS; Brasch JD; Simmons SF; Mixon AS; Norton SA
    Clin Ther; 2023 Oct; 45(10):947-956. PubMed ID: 37640614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Teaching Deprescribing and Combating Polypharmacy in the Pharmacy Curriculum: Educational Recommendations from Thematic Analysis of Focus Groups.
    Scott D; Cernasev A; Barenie RE; Springer SP; Axon DR
    Clin Pract; 2023 Mar; 13(2):442-453. PubMed ID: 36961065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beliefs and attitudes of residents, family members and healthcare professionals regarding deprescribing in long-term care: a qualitative study.
    Rowe S; Pittman N; Balsom C; Druken R; Kelly DV
    Int J Clin Pharm; 2022 Dec; 44(6):1370-1379. PubMed ID: 36201111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicians' views on pharmacists' involvement in hospital deprescribing: A qualitative study on proton pump inhibitors.
    Gendre P; Mayol S; Mocquard J; Huon JF
    Basic Clin Pharmacol Toxicol; 2023 Dec; 133(6):718-728. PubMed ID: 37081726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A qualitative study of stakeholder views and experiences of minor ailment services in the United Kingdom.
    Aly M; García-Cárdenas V; Williams KA; Benrimoj SI
    Res Social Adm Pharm; 2019 May; 15(5):496-504. PubMed ID: 29941403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barriers and enablers to deprescribing for older people in care homes: The theory-based perspectives of pharmacist independent prescribers.
    Alharthi M; Wright D; Scott S; Birt L
    Res Social Adm Pharm; 2023 May; 19(5):746-752. PubMed ID: 36732210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis.
    Reeve J; Maden M; Hill R; Turk A; Mahtani K; Wong G; Lasserson D; Krska J; Mangin D; Byng R; Wallace E; Ranson E
    Health Technol Assess; 2022 Jul; 26(32):1-148. PubMed ID: 35894932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers and enablers for deprescribing benzodiazepine receptor agonists in older adults: a systematic review of qualitative and quantitative studies using the theoretical domains framework.
    Evrard P; Pétein C; Beuscart JB; Spinewine A
    Implement Sci; 2022 Jul; 17(1):41. PubMed ID: 35804428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Views of medical practitioners about deprescribing in older adults: Findings from an Italian qualitative study.
    D'Avanzo B; Agosti P; Reeve E; Pasina L; Sabbà C; Mannucci PM; Nobili A
    Maturitas; 2020 Apr; 134():29-33. PubMed ID: 32143773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barriers and facilitators of successful deprescribing as described by older patients living with frailty, their informal carers and clinicians: a qualitative interview study.
    Peat G; Fylan B; Marques I; Raynor DK; Breen L; Olaniyan J; Alldred DP
    BMJ Open; 2022 Mar; 12(3):e054279. PubMed ID: 35351709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decision-maker and staff perceptions of the pharmacist's role in transitions of care programs.
    Foster AR; Gatewood SS; Kaefer TN; Goode JKR
    J Am Pharm Assoc (2003); 2019; 59(4S):S101-S105. PubMed ID: 31080151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.